VRTX
NASDAQ · Biotechnology
Vertex Pharmaceuticals Inc
$542.62
-4.41 (-0.81%)
EPS Surprise History
Earnings Summary
Beats (Last 7)
3/7
Avg Surprise
-0.9%
Latest EPS
$4.76
YoY EPS Growth
-0.8%
History
7 quarters
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | Q4 FY2026 | $4.86 | — | — | — | — |
| Sep 30, 2026 | Q3 FY2026 | $4.88 | $4.76 | -$0.12 | -2.5% | Miss |
| Aug 3, 2026 | Q3 FY2026 | $4.81 | — | — | — | — |
| Jun 30, 2026 | Q2 FY2026 | $4.83 | $4.73 | -$0.10 | -2.1% | Miss |
| May 4, 2026 | Q2 FY2026 | $4.41 | — | — | — | — |
| Mar 31, 2026 | Q1 FY2026 | $4.40 | $4.47 | +$0.07 | +1.6% | Beat |
| Feb 12, 2026 | Q1 FY2026 | $5.20 | — | — | — | — |
| Dec 31, 2025 | Q4 FY2025 | $5.17 | $5.03 | -$0.14 | -2.8% | Miss |
| Sep 30, 2025 | Q3 FY2025 | $4.65 | $4.80 | +$0.15 | +3.1% | Beat |
| Jun 30, 2025 | Q2 FY2025 | $4.37 | $4.52 | +$0.15 | +3.4% | Beat |
| Mar 31, 2025 | Q1 FY2025 | $4.37 | $4.06 | -$0.31 | -7.2% | Miss |